ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 117 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $343,350 | +0.1% | 21,800 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $343,000 | -75.4% | 21,800 | -78.2% | 0.00% | 0.0% |
Q2 2022 | $1,394,000 | -1.3% | 99,830 | +21.8% | 0.00% | 0.0% |
Q1 2022 | $1,413,000 | +71.3% | 81,965 | +44.2% | 0.00% | 0.0% |
Q4 2021 | $825,000 | -19.4% | 56,840 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,023,000 | – | 56,840 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |